Klingenstein Fields & CO LP Novo Nordisk A S Transaction History

Klingenstein Fields & CO LP

$2.49 Billion
Q2 2025

A detailed history of Klingenstein Fields & CO LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 9,955 shares of NVO stock, worth $489,288. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,955

Previous 10,235 2.74%

Holding current value

$489,288

Previous $710,000 3.24%

% of portfolio

0.03%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	SELL	$58.08 - $81.05 $16,262 - $22,694	-280 Reduced 2.74%	9,955 $687,000
Q1 2025 Apr 28, 2025	SELL	$69.3 - $90.95 $25,571 - $33,560	-369 Reduced 3.48%	10,235 $710,000
Q3 2024 Oct 29, 2024	SELL	$119.07 - $145.42 $13,812 - $16,868	-116 Reduced 1.08%	10,604 $1.26 Million
Q1 2024 Apr 29, 2024	SELL	$102.11 - $135.92 $16,950 - $22,562	-166 Reduced 1.52%	10,720 $1.38 Million
Q3 2023 Oct 27, 2023	BUY	$90.94 - $199.54 $489,530 - $1.07 Million	5,383 Added 97.82%	10,886 $989,000
Q2 2023 Aug 01, 2023	SELL	$155.98 - $172.65 $1,871 - $2,071	-12 Reduced 0.22%	5,503 $890,000
Q1 2023 Apr 28, 2023	SELL	$132.34 - $159.14 $13,234 - $15,913	-100 Reduced 1.78%	5,515 $877,000
Q4 2022 Feb 02, 2023	SELL	$102.55 - $135.33 $1,025 - $1,353	-10 Reduced 0.18%	5,615 $759,000
Q3 2022 Oct 28, 2022	SELL	$95.28 - $116.93 $2,858 - $3,507	-30 Reduced 0.53%	5,625 $560,000
Q2 2022 Aug 01, 2022	SELL	$103.24 - $121.81 $11,356 - $13,399	-110 Reduced 1.91%	5,655 $630,000
Q1 2022 Apr 27, 2022	SELL	$93.1 - $112.54 $13,965 - $16,881	-150 Reduced 2.54%	5,765 $640,000
Q4 2021 Jan 31, 2022	SELL	$95.88 - $117.08 $8,149 - $9,951	-85 Reduced 1.42%	5,915 $662,000
Q3 2021 Oct 26, 2021	SELL	$84.42 - $106.62 $8,442 - $10,662	-100 Reduced 1.64%	6,000 $576,000
Q2 2021 Jul 26, 2021	SELL	$67.66 - $84.76 $11,502 - $14,409	-170 Reduced 2.71%	6,100 $511,000
Q1 2021 Apr 29, 2021	SELL	$67.06 - $75.82 $18,977 - $21,457	-283 Reduced 4.32%	6,270 $423,000
Q3 2020 Oct 30, 2020	SELL	$63.69 - $70.22 $2,356 - $2,598	-37 Reduced 0.56%	6,553 $455,000
Q2 2020 Aug 03, 2020	SELL	$58.54 - $67.94 $3,219 - $3,736	-55 Reduced 0.83%	6,590 $432,000
Q1 2020 May 07, 2020	SELL	$49.46 - $64.78 $58,857 - $77,088	-1,190 Reduced 15.19%	6,645 $400,000
Q4 2019 Feb 04, 2020	SELL	$49.86 - $58.26 $11,218 - $13,108	-225 Reduced 2.79%	7,835 $453,000
Q3 2019 Nov 01, 2019	SELL	$47.54 - $53.43 $30,663 - $34,462	-645 Reduced 7.41%	8,060 $417,000
Q2 2019 Aug 12, 2019	SELL	$46.79 - $52.47 $9,358 - $10,494	-200 Reduced 2.25%	8,705 $444,000
Q1 2019 Apr 29, 2019	SELL	$46.36 - $52.63 $21,093 - $23,946	-455 Reduced 4.86%	8,905 $466,000
Q2 2018 Jul 26, 2018	SELL	$44.29 - $50.42 $2,878 - $3,277	-65 Reduced 0.69%	9,360 $432,000
Q1 2018 May 01, 2018	SELL	$48.49 - $58.14 $3,151 - $3,779	-65 Reduced 0.68%	9,425 $464,000
Q4 2017 Jan 30, 2018	SELL	$47.53 - $53.73 $6,416 - $7,253	-135 Reduced 1.4%	9,490 $509,000
Q3 2017 Nov 01, 2017	BUY	$41.15 - $49.22 $396,068 - $473,742	9,625	9,625 $463,000

Others Institutions Holding NVO

# of Institutions

1,685

Shares Held

286M

Call Options Held

14.8M

Put Options Held

22M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $111B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.

Account

Klingenstein Fields & CO LP Novo Nordisk A S Transaction History